[EN] SUBSTITUTED CHROMAN DERIVATIVES, MEDICAMENTS AND USE IN THERAPY<br/>[FR] DÉRIVÉS DE CHROMANE SUBSTITUÉS, MÉDICAMENTS ET UTILISATION À DES FINS THÉRAPEUTIQUES
申请人:NOVOGEN RES PTY LTD
公开号:WO2006032085A1
公开(公告)日:2006-03-30
Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
[EN] PRODUCTION OF ISOFLAVONE DERIVATIVES<br/>[FR] DERIVES D'ISOFLAVONE
申请人:NOVOGEN RES PTY LTD
公开号:WO2000049009A1
公开(公告)日:2000-08-24
Methods for the hydrogenation of isoflavones are described which provide access to workable quantities of isoflavan-4-ols, isoflav-3-enes, and isoflavans. The isoflavone derivatives can be obtained in high purity and in near quantitative yields whilst employing pharmaceutically acceptable reagents and solvents.
COMPOSITIONS AND THERAPEUTIC METHODS INVOLVING ISOFLAVONES AND ANALOGUES THEREOF
申请人:HEATON ANDREW
公开号:US20090233999A1
公开(公告)日:2009-09-17
Isoflavone compounds and analogues thereof, compositions containing same and therapeutic methods of treatment involving same are described.
本文讨论了异黄酮化合物及其类似物、含有它们的组合物以及涉及它们的治疗方法。
Substituted chroman derivatives, medicaments and use in therapy
申请人:Marshall Edwards, Inc.
公开号:EP2407462A1
公开(公告)日:2012-01-18
Novel substituted chroman derivatives and intermediate compounds, composition containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.